Mark R. Player

3.1k total citations
97 papers, 2.5k citations indexed

About

Mark R. Player is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Mark R. Player has authored 97 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 37 papers in Organic Chemistry and 14 papers in Oncology. Recurrent topics in Mark R. Player's work include Chemical Synthesis and Analysis (19 papers), DNA and Nucleic Acid Chemistry (14 papers) and Advancements in Transdermal Drug Delivery (11 papers). Mark R. Player is often cited by papers focused on Chemical Synthesis and Analysis (19 papers), DNA and Nucleic Acid Chemistry (14 papers) and Advancements in Transdermal Drug Delivery (11 papers). Mark R. Player collaborates with scholars based in United States, Belgium and United Kingdom. Mark R. Player's co-authors include Sharmila Patel, Raymond J. Patch, J. Walter Sowell, Bozena Michniak, Paul F. Torrence, Wing S. Cheung, Richard S. Pottorf, Naresh K. Chadha, Carsten J. Schubert and James Chapman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Diabetes.

In The Last Decade

Mark R. Player

97 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark R. Player United States 28 1.0k 924 308 304 264 97 2.5k
Alan L. Maycock United States 26 1.0k 1.0× 677 0.7× 150 0.5× 256 0.8× 344 1.3× 51 2.3k
Stephen J. Ballaron United States 20 925 0.9× 268 0.3× 45 0.1× 212 0.7× 383 1.5× 26 1.8k
Antonina Azzolina Italy 28 916 0.9× 177 0.2× 105 0.3× 201 0.7× 416 1.6× 53 2.0k
Anthony Marfat United States 26 898 0.9× 876 0.9× 114 0.4× 123 0.4× 475 1.8× 59 3.1k
George W. Carter United States 26 649 0.6× 525 0.6× 47 0.2× 186 0.6× 279 1.1× 58 1.7k
Guy G. Chabot France 32 1.6k 1.6× 481 0.5× 92 0.3× 712 2.3× 158 0.6× 67 3.1k
Won‐Jea Cho South Korea 24 1.1k 1.1× 956 1.0× 62 0.2× 237 0.8× 154 0.6× 76 2.3k
Donald S. Karanewsky United States 30 1.8k 1.8× 1.1k 1.2× 65 0.2× 362 1.2× 189 0.7× 77 3.0k
Michael M. Wick United States 27 984 1.0× 346 0.4× 30 0.1× 489 1.6× 300 1.1× 91 2.1k
Christopher R. Ireson United Kingdom 14 1.7k 1.6× 217 0.2× 145 0.5× 333 1.1× 137 0.5× 18 3.0k

Countries citing papers authored by Mark R. Player

Since Specialization
Citations

This map shows the geographic impact of Mark R. Player's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Player with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Player more than expected).

Fields of papers citing papers by Mark R. Player

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark R. Player. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Player. The network helps show where Mark R. Player may publish in the future.

Co-authorship network of co-authors of Mark R. Player

This figure shows the co-authorship network connecting the top 25 collaborators of Mark R. Player. A scholar is included among the top collaborators of Mark R. Player based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark R. Player. Mark R. Player is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Jianying, Hui Huang, Jenson Qi, et al.. (2022). A FFAR1 full agonist restores islet function in models of impaired glucose-stimulated insulin secretion and diabetic non-human primates. Frontiers in Endocrinology. 13. 1061688–1061688. 7 indexed citations
2.
Huang, Hui, Sanath K. Meegalla, James C. Lanter, et al.. (2018). Discovery of a GPR40 Superagonist: The Impact of Aryl Propionic Acid α-Fluorination. ACS Medicinal Chemistry Letters. 10(1). 16–21. 18 indexed citations
3.
Otieno, Monicah A., Jan Snoeys, Wing Lam, et al.. (2017). Fasiglifam (TAK-875): Mechanistic Investigation and Retrospective Identification of Hazards for Drug Induced Liver Injury. Toxicological Sciences. 163(2). 374–384. 66 indexed citations
4.
Patch, Raymond J., Hui Huang, Sharmila Patel, et al.. (2017). Indazole-based ligands for estrogen-related receptor α as potential anti-diabetic agents. European Journal of Medicinal Chemistry. 138. 830–853. 30 indexed citations
5.
Meegalla, Sanath K., Hui Huang, Carl R. Illig, et al.. (2016). Discovery of novel potent imidazo[1,2-b]pyridazine PDE10a inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(17). 4216–4222. 11 indexed citations
6.
Balasubramanian, Adithya, et al.. (2013). Shivering and tachycardic responses to external cooling in mice are substantially suppressed by TRPV1 activation but not by TRPM8 inhibition. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 305(9). R1040–R1050. 31 indexed citations
7.
Player, Mark R., et al.. (2009). Developments in factor Xa inhibitors for the treatment of thromboembolic disorders. Medicinal Research Reviews. 31(2). 202–283. 22 indexed citations
8.
Patel, Sharmila & Mark R. Player. (2009). Colony-Stimulating Factor-1 Receptor Inhibitors for the Treatment of Cancer and Inflammatory Disease. Current Topics in Medicinal Chemistry. 9(7). 599–610. 98 indexed citations
9.
Meegalla, Sanath K., Mark J. Wall, Kenneth J. Wilson, et al.. (2008). Structure-based optimization of a potent class of arylamide FMS inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(12). 3632–3637. 26 indexed citations
10.
Illig, Carl R., Mark J. Wall, Kenneth J. Wilson, et al.. (2008). Discovery of novel FMS kinase inhibitors as anti-inflammatory agents. Bioorganic & Medicinal Chemistry Letters. 18(5). 1642–1648. 40 indexed citations
11.
Kreutter, K. D., Tianbao Lu, Lily Lee, et al.. (2008). Orally efficacious thrombin inhibitors with cyanofluorophenylacetamide as the P2 motif. Bioorganic & Medicinal Chemistry Letters. 18(9). 2865–2870. 24 indexed citations
12.
Patel, Sharmila & Mark R. Player. (2008). Small-molecule inhibitors of the p53-HDM2 interaction for the treatment of cancer. Expert Opinion on Investigational Drugs. 17(12). 1865–1882. 82 indexed citations
13.
Patch, Raymond J., Benjamin Brandt, Davoud Asgari, et al.. (2007). Potent 2′-aminoanilide inhibitors of cFMS as potential anti-inflammatory agents. Bioorganic & Medicinal Chemistry Letters. 17(22). 6070–6074. 24 indexed citations
14.
Maryanoff, Bruce E., David F. McComsey, Michael J. Costanzo, et al.. (2006). Exploration of Potential Prodrugs of RWJ‐445167, an Oxyguanidine‐based Dual Inhibitor of Thrombin and Factor Xa. Chemical Biology & Drug Design. 68(1). 29–36. 19 indexed citations
15.
Schubert, Carsten J., Céline Schalk‐Hihi, Geoffrey T. Struble, et al.. (2006). Crystal Structure of the Tyrosine Kinase Domain of Colony-stimulating Factor-1 Receptor (cFMS) in Complex with Two Inhibitors. Journal of Biological Chemistry. 282(6). 4094–4101. 56 indexed citations
16.
Cramer, H., Mark R. Player, & Paul F. Torrence. (1999). Discrimination between ribonuclease H- and ribonuclease L-mediated RNA degradation by 2′-O-methylated 2-5A-antisense oligonucleotides. Bioorganic & Medicinal Chemistry Letters. 9(7). 1049–1054. 9 indexed citations
17.
Verheijen, Jeroen C., et al.. (1999). 2-5A-PNA Complexes: A Novel Class of Antisense Compounds. Nucleosides and Nucleotides. 18(6-7). 1485–1486. 3 indexed citations
18.
Player, Mark R. & Paul F. Torrence. (1999). Phosphorothioate oligodeoxyribonucleotides inhibit ribonuclease L thereby disabling a mechanism of interferon action. Bioorganic & Medicinal Chemistry Letters. 9(6). 891–894. 3 indexed citations
19.
Player, Mark R., et al.. (1998). Dissection of the Roles of Adenine Ring Nitrogen (N-1) and Exocyclic Amino (N-6) Moieties in the Interaction of 2-5A with RNase L. Biochemical and Biophysical Research Communications. 245(2). 430–434. 4 indexed citations
20.
Michniak, Bozena, Mark R. Player, & J. Walter Sowell. (1996). Synthesis and in Vitro Transdermal Penetration Enhancing Activity of Lactam N-Acetic Acid Esters. Journal of Pharmaceutical Sciences. 85(2). 150–154. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alan L. Maycock Breakdown of academic impact, for papers by Stephen J. Ballaron Breakdown of academic impact, for papers by Antonina Azzolina Breakdown of academic impact, for papers by Anthony Marfat Breakdown of academic impact, for papers by George W. Carter Breakdown of academic impact, for papers by Guy G. Chabot Breakdown of academic impact, for papers by Won‐Jea Cho Breakdown of academic impact, for papers by Donald S. Karanewsky Breakdown of academic impact, for papers by Michael M. Wick Breakdown of academic impact, for papers by Christopher R. Ireson
Rankless by CCL
2026